More Publications

1.     C. Imberti†, R. De Gregorio†, J. A. Korsen, T. T. Hoang, S. Kithrov, T. Kalidindi, S. Nandakumar, J. Park, S. Zaidi, N.V. K. Pillarsetty, J. S. Lewis, “CEACAM5-targeted immunoPET in androgen receptor negative prostate cancer”, J. Nucl. Med., https://doi.org/10.2967/jnumed.123.267107

2.     H. Shi, O. W. L.  Carter, F. Ponte, C. Imberti, M. A. Gomez‐Gonzalez, F. Cacho‐Nerin, P. D. Quinn, J. E. Parker, E. Sicilia, H. Huang, P. J. Sadler, “A Photodynamic and Photochemotherapeutic Platinum‐Iridium Charge‐Transfer Conjugate for Anticancer Therapy”, Angew. Chem. Int. Ed., (2024), e202400476

3.     H. Shi, F. Ponte, J. S. Grewal, G. J Clarkson, C. Imberti, I. Hands-Portman, R. Dallmann, E. Sicilia, P. J. Sadler, “Tuning the photoactivated anticancer activity of Pt(IV) compounds via distant ferrocene conjugation”, Chem. Sci., (2024), 15, 4121-4134.

4.     A. M. F. Darwesh, C. Imberti, J. J. Bartnicka, F. Al-Salemee, J. E. Blower, A. Rigby, J.Bordoloi, A. Griffiths, M.T. Ma, P. J. Blower, “In Vivo Trafficking of the Anticancer Drug Tris (8-Quinolinolato) Gallium (III)(KP46) by Gallium-68/67 PET/SPECT Imaging” Molecules (2023), 28, 7217.

5. C. Imberti*,  J. Lok,  J. P.C. Coverdale, O. W. L. Carter, M. E. Fry, M. L. Postings, J. Kim, G. Firth, P. J. Blower, P. J. Sadler* ,“Radiometal-Labeled Photoactivatable Pt(IV) Anticancer Complex for Theranostic Phototherapy” Inorg. Chem. (2023), 62, 20745–20753.

6.     A. Sink, S. Banerjee, J. A. Wolny, C. Imberti, E. C. Lant, M. Walker, V. Schünemann and P. J.  Sadler, “Kinetics and mechanism of sequential ring methyl C–H activation in cyclopentadienyl rhodium (III) complexes“ Dalton Trans. (2022), 51, 16070.

7. E. M. Bolitho, C. Sanchez-Cano, H. Shi, P. D. Quinn*, M. Harkiolaki*, C. Imberti* and P. J. Sadler*, “Single cell chemistry of photoactivatable platinum anticancer complexes”, J. Am. Chem. Soc. (2021), 143, 20224-20240.

8.     C. Imberti*, F. Lermyte, E. P. Friar, P. O’Connor and P. J. Sadler*, “Facile protein conjugation of platinum for light-activated cytotoxic payload release” Chem. Commun., (2021), 57, 7645-7648.

9.     E. Verger, J. Cheng, V. de Santis, M. Iafrate, J. A. Jackson, C. Imberti, G. O. Fruhwirth, P. J. Blower, M. T. Ma, D. R. Burnham, S. Y. A. Terry, “Validation of the plasmid study to relate DNA damaging effects of radionuclides to those from external beam radiotherapy”, Nucl. Med. Biol., (2021), 98-99, 18-29.

10.  I. M. Costa, J. Cheng, K. M. Osytek, C. Imberti and S. Y. A. Terry, “Methods and techniques for in vitro subcellular localization of radiopharmaceuticals and radionuclides” Nucl. Med. Biol., (2021), 100-101,36-43.

11.  H. Shi, J. Kasparkova, C. Soulié, G. J. Clarkson, C. Imberti, O. Novakova, M. J. Paterson, V. Brabec and P. J. Sadler, “DNA-Intercalative platinum anticancer complexes photoactivated by visible light”, Chem. Eur. J., (2021), 27, 1-7.

12. E. J. Anthony, E. M. Bolitho, H. E. Bridgewater, O. W.L. Carter, J. M. Donnelly, C. Imberti*, E. C. Lant, F. Lermyte, R. J. Needham, M. Palau, P. J. Sadler*, H. Shi, F. Wang, W. Zhang, Z. Zhang, “Metallodrugs are unique: opportunities and challenges of discovery and development” Chem. Sci